These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☒
|
Definitive Proxy Statement
|
|
☐
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material Pursuant to Rule 14a-12
|
|
☒
|
No fee required.
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
When:
|
Where:
|
|
Thursday, September 13, 2018
8:00 a.m. ET
|
The Westin Washington Dulles Airport
2520 Wasser Terrace,
Herndon, Virginia 20171
|
| 1. |
To elect as directors the nine nominees named in the attached proxy statement, each to serve an annual term, and until their successors have been duly elected and qualified;
|
| 2. |
To hold an advisory vote on the compensation of our named executive officers as disclosed in the proxy statement;
|
| 4. |
To ratify the selection of Deloitte & Touche LLP (“Deloitte”) as our independent registered accounting firm for our fiscal year ending March 31, 2019;
|
| 6. |
To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
|
July 27, 2018
|
By Order of the Board of Directors
|
|
Erica S. Stoecker
|
|
|
Corporate Secretary & General Counsel
|
|
1
|
||
|
1
|
||
|
1
|
||
|
1
|
||
|
1
|
||
|
2
|
||
|
2
|
||
|
3
|
||
|
3
|
||
|
3
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
5
|
||
|
5
|
||
|
5
|
||
|
6
|
||
|
8
|
||
|
8
|
||
|
9
|
||
|
9
|
||
|
9
|
||
|
9
|
||
|
10
|
||
|
11
|
||
|
11
|
||
|
11
|
||
|
12
|
||
|
16
|
||
|
17
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
20
|
||
|
21
|
||
|
21
|
||
|
22
|
||
|
22
|
||
|
23
|
||
|
23
|
||
|
24
|
||
|
24
|
||
|
25
|
||
|
25
|
||
|
25
|
||
|
25
|
||
|
26
|
||
|
28
|
||
|
29
|
||
|
31
|
||
|
32
|
||
|
32
|
||
|
32
|
||
|
33
|
||
|
33
|
||
|
34
|
||
|
34
|
||
|
35
|
||
|
36
|
||
|
36
|
||
|
37
|
||
| EQUITY COMPENSATION PLAN INFORMATION |
40
|
|
| PROPOSAL 3 – Ratification of the Selection of Deloitte & Touche LLP as our Independent Registered Public Accounting Firm for our Fiscal Year Ending March 31, 2019 |
41
|
|
| AUDIT COMMITTEE REPORT |
41
|
|
|
42
|
||
|
43
|
||
| OTHER MATTERS |
46
|
|
|
46
|
||
|
47
|
||
|
47
|
||
|
47
|
||
|
48
|
||
|
48
|
||
|
48
|
||
|
Who:
|
Shareholders as of the Record Date, July 19, 2018
|
|
What:
|
See detailed Proposals on pages 11, 21 and 41, and summaries below
|
|
When:
|
September 13, 2018, 8:00 a.m. ET
|
|
Where:
|
The Westin Washington Dulles Airport, 2520 Wasser Terrace, Herndon, Virginia, 20171
|
|
How:
|
Internet/Mobile, Phone, Mail, In Person (see Voting Information beginning on page 3 for details)
|
|
ePlus 2018 Director Nominees
|
||||||||||||||||||||
|
Board Committees
|
||||||||||||||||||||
|
Name
|
Age
|
Audit
|
Compensation
|
Nominating
& Corporate
Governance
|
Number of
Other Public
Company Boards
|
|||||||||||||||
|
Phillip G. Norton, Executive Chairman
|
74
|
0
|
||||||||||||||||||
|
Bruce M. Bowen
|
66
|
0
|
||||||||||||||||||
|
John E. Callies*
|
64
|
X
|
|
X
|
|
0
|
||||||||||||||
|
C. Thomas Faulders, III*, Lead Independent Director
|
68
|
X
|
X
|
|
0
|
|||||||||||||||
|
Lawrence S. Herman*
|
74
|
X
|
|
X
|
|
0
|
||||||||||||||
|
Eric D. Hovde*
|
54
|
X
|
|
X
|
|
1
|
||||||||||||||
|
Ira A. Hunt, III*
|
62
|
X
|
|
X
|
|
0
|
||||||||||||||
|
Maureen F. Morrison*
|
63
|
X
|
|
1
|
||||||||||||||||
|
Terrence O’Donnell*
|
74
|
X
|
|
X
|
|
0
|
||||||||||||||
|
More
Information
|
Board
Recommendation
|
||
|
Proposal 1
|
Election of Directors
|
Page 11
|
FOR each Director Nominee
|
|
Proposal 2
|
Advisory Vote to Approve Named Executive Officers’ Compensation
|
Page 21
|
FOR
|
|
Proposal 3
|
Ratification of Independent Registered Public Accounting Firm
|
Page 41
|
FOR
|
|
INTERNET / MOBILE
|
PHONE
|
MAIL
|
||
|
|
|
||
|
Visit 24/7:
www.investorvote.com/plus
Use the Internet to vote your proxy until 11:59 p.m. ET on September 12, 2018
|
Dial toll free 24/7
Use a touch-tone telephone to vote your proxy until 11:59 p.m. ET on September 12, 2018
|
Mark, sign, and date your proxy card, and return it in the postage-paid envelope provided, such that it is received no later than 8:00 a.m. ET on September 13, 2018
|
|
Audit Committee
Chair:
Terrence O’Donnell
Other Com
mittee
Members :
John E. Callies, C. Thomas Faulders, Lawrence S. Herman, Maureen F. Morrison*
Meetings Held in FY2018:
10
Primary Responsibilities:
Our Audit Committee is responsible for, among other things: (1) appointing, compensating, retaining, and overseeing the work of the independent auditor engaged to prepare or issue audit reports and perform other audit, review, or attest services for the Company; (2) discussing the annual audited financial statements with management and the Company’s independent auditor, including the Company’s disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”), and recommending to the Board whether the audited financial statements should be included in the Company’s yearly Annual Report on Form 10-K; (3) discussing the Company’s unaudited financial statements and related footnotes and the MD&A portion of the Company’s Form 10-Q for each interim quarter with management and the independent auditor, as appropriate; (4) overseeing the Company’s internal audit function; and (5) discussing the earnings press releases and financial information and earnings guidance, if any, provided to analysts and ratings agencies with management and/or the independent auditor, as appropriate.
Each member of the Audit Committee is financially literate, knowledgeable, and qualified to review financial statements. The Board has determined that C. Thomas Faulders and Maureen F. Morrison meet the definition of an “audit committee financial expert” under the Exchange Act rules.
Independence:
Each Audit Committee member meets the audit committee independence requirements of NASDAQ and the rules under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
*On June 12, 2018, Ms. Morrison joined ePlus’ Board, and was appointed to the Audit Committee.
|
|
Compensation Committee
Chair:
John E. Callies
Other Members of the Committee:
Ira A. Hunt, C. Thomas Faulders, Eric D. Hovde
Meetings Held in FY2018:
6
Primary Responsibilities:
Our Compensation Committee is responsible for, among other things: (1) reviewing and approving, and recommending for Board ratification, the corporate goals and objectives applicable to the compensation of the Company’s Chief Executive Officer (“CEO”) and other executive officers; (2) reviewing and approving and, if required by law, recommending for Board approval incentive compensation and equity-based plans, and, where appropriate or required, recommending such plans for shareholder approval; (3) reviewing the Company’s incentive compensation arrangements to determine whether they encourage excessive risk-taking, reviewing and discussing the relationship between risk management policies and practices and executive compensation, and evaluating policies and practices that could mitigate any such risk; (4) reviewing and discussing with management the Compensation Discussion and Analysis (“CD&A”) and related executive compensation information, and recommending that the same for inclusion in the Company’s proxy statement or yearly Annual Report; (5) reviewing and recommending for Board approval the frequency with which the Company conducts Say on Pay votes, and approving proposals regarding the Say on Pay Vote; (6) directly responsible for the appointing, compensating, and overseeing of any work of any Compensation consultant, legal counsel, or other advisor the Committee retains; and (7) reviewing and approving, or reviewing and recommending for Board approval, employment agreements and severance/change in control agreements for the Company’s executive officers.
Independence:
Each member of the Compensation Committee meets the compensation committee independence requirements of NASDAQ and the rules under the Exchange Act, as well as the non-employee director requirements of Rule 16b-3 under the Exchange Act, and the outside director requirements under Section 162(m) of the Internal Revenue Code (“IRC”).
|
|
Nominating and Corporate Governance Committee
Chair:
Lawrence S. Herman
Other Members of the Committee:
Ira A. Hunt, Eric D. Hovde, Terrence O’Donnell
Meetings Held in FY2018:
6
Primary Responsibilities:
Our Nominating and Corporate Governance Committee is responsible for, among other things: (1) selecting and recommending nominees for director to the Board; (2) recommending committee composition to the Board ; (3) overseeing the evaluation of the Board and each of its committees; (4) reviewing and recommending compensation of non-employee directors to the Board; (5) reviewing our related party transaction policy, and any related party transactions; (6) overseeing management’s development and succession planning; and (7) reviewing and assessing the adequacy of our corporate governance framework, including our Certificate of Incorporation, Bylaws, and Corporate Governance Guidelines, and making recommendations to the Board as appropriate.
Independence
:
Each member of the Nominating and Corporate Governance Committee meets NASDAQ’s independence requirements.
|
| · |
Unquestioned personal ethics and integrity;
|
| · |
Specific skills and experience that aligns with ePlus’ strategic direction and operating challenges, and complements the Board’s overall composition;
|
| · |
Diversity of skills and experience;
|
| · |
Core business competencies of high achievement and a record of success;
|
| · |
Financial literacy, exposure to best practices, and track-record of making good business decisions;
|
| · |
Interpersonal skills that maximize group dynamics; and
|
| · |
Enthusiasm about ePlus and sufficient time to become fully engaged.
|
|
Phillip G. Norton
|
Director of ePlus since: 1993
|
|||
|
Executive Chairman
|
||||
|
Age 74
|
Other Public Company Directorships: None
|
|
Bruce M. Bowen
|
Director of ePlus since: 1990
|
|||
|
Retired ePlus Executive Vice President
|
||||
|
Age 66
|
Other Public Company Directorships: None
|
|
Terrence O’Donnell
|
Director of ePlus since: 1996
|
|||
|
Independent Director
|
Committees: Audit; Nominating and Corporate Governance
|
|||
|
Age 74
|
||||
|
Other Public Company Directorships: None
|
| C. Thomas Faulders, III | Director of ePlus since: 1998 | |||
|
|
||||
| Independent Director | Committees: Audit; Compensation | |||
| Age 68 | ||||
| Other Public Company Directorships: None |
|
Lawrence S. Herman
|
Director of ePlus since: 2001
|
|||
|
Independent Director
|
Committees: Audit; Nominating and Corporate Governance
|
|||
| Age 74 | ||||
|
Other Public Company Directorships: None
|
|
Eric D. Hovde
|
Director of ePlus since: 2006
|
|||
|
Independent Director
|
Committees: Compensation; Nominating and Corporate Governance
|
|||
|
Age 54
|
||||
|
Other Public Company Directorships: Old Line Bancshares, Inc..
|
|
John E. Callies
Independent Director
Age 64
|
Director of ePlus since: 2010
Committees: Audit; Compensation
Other Public Company Directorships: None
|
|
Ira A. Hunt, III
|
Director of ePlus since: 2014
|
|||
|
Independent Director
|
Committees: Compensation; Nominating and Corporate Governance
|
|||
|
Age 62
|
||||
|
Other Public Company Directorships: None
|
|
Maureen F. Morrison
|
Director of ePlus since: 2018
|
|||
|
Independent Director
|
Committees: Audit
|
|||
|
Age 63
|
||||
|
Other Public Company Directorships: Safeguard Scientifics, Inc.
|
|
Name
|
Fees Earned or
Paid in Cash
($)(1)
|
Stock
Awards
($)(2)(3)
|
Option
Awards
($)
|
All Other
Compensation
($)
|
Total
($)
|
|||||||||||||||
|
John E. Callies
|
75,000
|
74,933
|
-
|
-
|
149,933
|
|||||||||||||||
|
Ira A. Hunt, III
|
75,000
|
74,933
|
-
|
-
|
149,933
|
|||||||||||||||
|
C. Thomas Faulders, III
|
75,000
|
74,933
|
-
|
-
|
149,933
|
|||||||||||||||
|
Lawrence S. Herman
|
75,000
|
74,933
|
-
|
-
|
149,933
|
|||||||||||||||
|
Eric D. Hovde
|
75,000
|
74,933
|
-
|
-
|
149,933
|
|||||||||||||||
|
Terrence O’Donnell
|
75,000
|
74,933
|
-
|
-
|
149,933
|
|||||||||||||||
|
Bruce Bowen (4)
|
200,000
|
-
|
-
|
3,800
|
203,800
|
|||||||||||||||
|
(1)
|
The above table reflects fees earned during the fiscal year 2018. Pursuant to our 2017 Non-Employee Director Long-Term Incentive Plan (“2017 Director LTIP”), directors may make a stock fee election, through which they receive shares of restricted stock in lieu of cash compensation. The stock fee elections are made on a calendar year basis, and the stock grant is made on the first business day after the end of each quarter of board services. The number of shares received is determined by dividing $18,750 (the cash compensation earned quarterly by directors) by the Fair Market Value of a share of common stock, as defined in the 2017 Director LTIP, and rounding down to avoid a fractional share.
|
|
Board Service Time
|
Number of
Shares Granted
|
|||
|
April 1, 2017 - June 30, 2017
|
253
|
|||
|
July 1, 2017 - September 30, 2017
|
198
|
|||
|
October 1, 2017 - December 31, 2017
|
248
|
|||
|
January 1, 2018 - March 31, 2018
|
241
|
|||
| (2) |
The values in this column represent the aggregate grant date fair market values of the fiscal year 2018 restricted stock awards, computed in accordance with
Codification Topic
Compensation
—Stock Compensation
.
|
|
(3)
|
The table below reflects the aggregate number of unvested restricted stock shares outstanding as of March 31, 2018, for each director except Mr. Norton, who was an executive officer, and Ms. Morrison, who joined the board in June 2018.
|
|
Name
|
Number of
Restricted
Stock Shares
|
|||
|
John E. Callies
|
1,691
|
|||
|
Ira A. Hunt, III
|
1,691
|
|||
|
C. Thomas Faulders, III
|
1,691
|
|||
|
Lawrence S. Herman
|
1,691
|
|||
|
Eric D. Hovde
|
1,691
|
|||
|
Terrence O’Donnell
|
3,361
|
|||
|
Bruce Bowen
|
-
|
|||
| (4) |
During the fiscal year ended March 31, 2018, our Senior Vice President of Business Development was not an executive officer. This table reflects compensation paid to him as an employee, not as a director. Mr. Bowen’s compensation also includes a $3,500 company match to his 401(k) plan and a $300 “medical waiver” payment in accordance with the Company’s policy applicable to all eligible employees who decline the Company’s health insurance.
|
| · |
each member of our Board of Directors, each director nominee and each of our named executive officers (“NEO”);
|
| · |
all members of our Board and our executive officers as a group; and
|
| · |
each person or group who is known by us to own beneficially more than 5% of our common stock.
|
|
Directors and Executive Officers
|
|
Name
|
Aggregate
Number of
Beneficial
Shares
|
Percent of
Outstanding
Shares
|
Additional Information (1)
|
|
Phillip G. Norton
|
29,599
|
*
|
---
|
|
Bruce M. Bowen
|
15,934
|
*
|
Includes 10,000 shares of common stock held by Bowen Holdings LLC, a Virginia limited liability company, which is owned by Mr. Bowen and his three adult children, for which shares Mr. Bowen serves as manager. Also includes 2,782 shares each held by the Elizabeth Dederich Bowen Trust and the Bruce Montague Bowen Trust.
|
|
John E. Callies
|
11,154
|
*
|
Includes 1,691 shares of restricted stock that has not vested as of July 19, 2018.
|
|
C. Thomas Faulders III
|
23,301
|
*
|
Includes 1,691 shares of restricted stock that has not vested as of July 19, 2018.
|
|
Lawrence S. Herman
|
12,052
|
*
|
Includes 1,691 shares of restricted stock that has not vested as of July 19, 2018.
|
|
Eric D. Hovde
|
52,494
|
*
|
Includes 1,691 shares of restricted stock that has not vested as of July 19, 2018. Mr. Hovde is the managing member of Hovde Capital, Ltd., the general partner to Financial Institution Partners III LP, which owns 10,198 shares. Mr. Hovde is a trustee of The Eric D. and Steven D. Hovde Foundation, which owns 8,277 shares.
|
|
Ira A. Hunt III
|
7,214
|
*
|
Includes 1,691 shares of restricted stock that has not vested as of July 19, 2018.
|
|
Terrence O’Donnell
|
10,952
|
*
|
Includes 3,361 shares of restricted stock that has not vested as of July 19, 2018.
|
|
Maureen F. Morrison
|
230
|
*
|
Includes 230 shares of restricted stock that has not vested as of July 19, 2018
|
|
Mark P. Marron
|
110,699
|
*
|
Includes 89,616 shares of restricted stock that has not vested as of July 19, 2018, and 1,775 shares held in Trust.
|
|
Elaine D. Marion
|
71,934
|
*
|
Includes 48,006 shares of restricted stock that has not vested as of July 19, 2018.
|
|
Darren S. Raiguel
|
33,983
|
*
|
Includes 16,236 shares of restricted stock that has not vested as of July 19, 2018.
|
|
All directors and executive
officers as a group (12 persons)
|
379,546
|
2.72%
|
| * |
Less than 1%
|
| (1) |
The business address of Mses. Morrison and Marion and Messrs. Norton, Bowen, Marron, Raiguel, Faulders, O’Donnell, Hunt, Herman, Hovde and Callies is 13595 Dulles Technology Drive, Herndon, Virginia 20171.
|
|
Principal Shareholders
|
|
Name of Beneficial Owner
|
Aggregate
Number of
Beneficial Shares
|
Percent of
Outstanding
Shares
|
||||||
|
BlackRock, Inc. (1)
|
1,726,060
|
12.37
|
%
|
|||||
|
Dimensional Fund Advisors LP (2)
|
1,125,188
|
8.06
|
%
|
|||||
|
FMR LLC (3)
|
1,089,536
|
7.81
|
%
|
|||||
|
The Vanguard Group (4)
|
1,035,239
|
7.42
|
%
|
|||||
| (1) |
The information as to BlackRock, Inc., located at 55 East 52nd Street, New York, New York 10055, is based on a Schedule 13G/A filed with the SEC on January 19, 2018. BlackRock indicates in its Schedule 13G that no one person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, or has an interest in the common stock of, more than five percent of ePlus stock.
|
| (2) |
The information as to Dimensional Fund Advisors LP, located at Building One, 6300 Bee Cave Road, Austin, Texas 78746, is based on a Schedule 13G/A filed with the SEC on February 9, 2018. Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the “Funds”). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, “Dimensional”) may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds, and may be deemed to be the beneficial owner of the shares of the Issuer held by the Funds. However, all securities reported in this schedule are owned by the Funds. Dimensional disclaims beneficial ownership of such securities.
|
| (3) |
The information as to FMR LLC, located at 245 Summer Street, Boston, Massachusetts 02210, is based on a Schedule 13G filed with the SEC on February 13, 2018. The shares are directly owned by various investment companies advised by Fidelity Management and Research Company, a wholly-owned subsidiary of FMR LLC.
|
| (4) |
The information as to The Vanguard Group, located at 100 Vanguard Boulevard, Malvern, Pennsylvania 19355, is based on a Schedule 13G/A filed with the SEC on February 9, 2018.
|
|
Mark P. Marron
President and Chief Executive Officer
Age 57
|
|
Elaine D. Marion
Chief Financial Officer
Age 50
|
|
Name
|
Title
|
|
Phillip G. Norton
|
Executive Chairman
|
|
Mark P. Marron
|
President and Chief Executive Officer
|
|
Elaine D. Marion
|
Chief Financial Officer
|
|
Overview
|
·
Fiscal Year 2018 Business Highlights
·
Our Executive Compensation Program
·
Our Executive Compensation Practices
·
2017 Say-On-Pay Vote
|
|
|
What We Pay and Why
|
·
Fiscal Year 2018 Executive Compensation Decisions
·
Base Salary
·
Annual Cash Incentive Awards
·
Long-Term Equity Based Incentive Program
·
Other Elements of Our Fiscal Year 2018 Executive Compensation Program
|
|
|
How We Make Executive Compensation Decisions
|
·
Role of the Board, Compensation Committee and our Executive Officers
·
Guidance from the Compensation Committee’s Independent Compensation Consultant
·
Comparison Peer Groups
·
Alignment of Senior Management Team to Drive Performance
|
| · |
Net sales increased 6.1% to $1,411 billion from fiscal year 2017
|
| · |
Consolidated gross profit increased 7.9% to $323.5 million from the prior year
|
| · |
Operating income decreased 1.7% to $84.2 million from the prior year
|
| · |
Net earnings were $55.1 million, a 9.0% increase over the prior year
|
| · |
Diluted earnings per share increased 9.7% to $3.95.
|
|
Pay Element
|
||||
|
Salary
|
Annual Cash Incentive
|
Restricted Stock
|
||
|
Who Receives -- All NEOs
|
|
|||
|
When Granted
|
Annually
|
|||
|
Form of Delivery
|
Cash
|
Equity
|
||
|
Type of Performance
|
Short-term fixed
|
Short-term variable
|
Long-term fixed
|
|
|
Performance Period
|
1 year
|
1 year
|
Vesting annually over 2 to 5 years
|
|
|
How Payout Determined
|
Compensation Committee determination
|
Based upon formula established by Compensation Committee
|
Compensation Committee determination
|
|
|
Performance Measures
|
Individual
|
Financing origination volume, earnings before tax
|
||
|
Our Executive Compensation Practices
|
|
|
✓
Significant percentage of cash compensation delivered in the form of variable compensation, which is “at-risk” and tied to quantifiable performance measures
✓
Long-term vesting of restricted stock, to align executive and shareholder interests
✓
Compensation Committee consists of independent directors only
✓
Annual review of our compensation programs
✓
Market comparison of executive compensation against relevant peer group information
✓
Periodic use of an independent compensation consultant reporting directly to the Compensation Committee and providing no services to the Company
✓
Executive officer stock ownership guidelines
✓
Clawback policy
|
|
|
X
No excessive executive perquisites
X
No excessive severance benefits
X
No hedging or short sales of our securities, and we do not allow pledging of our securities, except in limited circumstances with pre-approval
|
|
Base salary as of March 31,
|
||||||||
|
Named Executive Officer
|
2018
|
2017
|
||||||
|
Phillip G. Norton
|
$
|
300,000
|
$
|
300,000
|
||||
|
Mark P. Marron
|
$
|
750,000
|
$
|
700,000
|
||||
|
Elaine D. Marion
|
$
|
450,000
|
$
|
415,000
|
||||
|
EBT
|
Origination
|
|||||||||||||||
|
Named Executive Officer
|
Percentage of
Total Bonus
|
Target
Amount ($) |
Percentage of
Total Bonus
|
Target
Amount ($)
|
||||||||||||
|
Phillip G. Norton
|
85.0
|
%
|
127,500
|
15.0
|
%
|
22,500
|
||||||||||
|
Mark P. Marron
|
85.0
|
%
|
510,000
|
15.0
|
%
|
90,000
|
||||||||||
|
Elaine D. Marion
|
85.0
|
%
|
212,500
|
15.0
|
%
|
37,500
|
||||||||||
|
Performance Goals
|
||||||||
|
Performance Level
|
Earnings
Before Taxes |
Financing
Origination Volume |
||||||
|
Maximum
|
n/a
|
(1)
|
n/a
|
(1)
|
||||
|
Target
|
$
|
92,821,500
|
$
|
363,500,000
|
||||
|
Threshold (75% of Performance Goal)
|
$
|
69,616,125
|
$
|
272,625,000
|
||||
|
Below Threshold
|
<$69,616,125
|
<$272,625,000
|
||||||
| (1) |
The threshold and escalators for each performance goal are as follows:
|
|
Amount of Goal Achieved
|
Award Amount
|
||
|
Less than 75% of Goal Target
|
No award relating to that target
|
||
|
Between 75% - 100% of Goal Target
|
Award shall be 50% of target, plus an additional 2.0% for each percentage point over 75% of Goal Target achieved
|
||
|
100% of Goal Target
|
100% of target for that Goal
|
||
|
More than 100% of Goal Target
|
100% of target for that Goal, plus an additional 5.0% for each percentage point over 100% of Goal Target achieved
|
||
|
Total Maximum Award for all goals combined
|
200% of Target
|
|
Performance Criteria
|
Goal
|
Achievement
|
Percentage Payout
|
|||||||||
|
EBT
|
$
|
92,821,500
|
$
|
85,132,861(1
|
)
|
91.7
|
%
|
|||||
|
Origination
|
$
|
363,500,000
|
$
|
385,484,000
|
106.0
|
%
|
||||||
| (1) |
Actual earnings before taxes were adjusted to exclude the incentive compensation accrued by the Company, and results for entities acquired during fiscal year 2018.
|
|
Named Executive Officer
|
FY 2018 Annual Incentive
Cash Payment Earned ($)
|
FY 2017 Annual Incentive
Cash Payment Earned ($)
|
% Change
|
|||||||||
|
Phillip G. Norton (1)
|
378,253
|
428,088
|
(12
|
%)
|
||||||||
|
Mark P. Marron (2)
|
605,204
|
261,609
|
131
|
%
|
||||||||
|
Elaine D. Marion
|
313,950
|
190,261
|
65
|
%
|
||||||||
| (1) |
The decrease in Mr. Norton’s compensation is attributable in part to the reduction of his cash incentive compensation in connection with his August 2016 transition from CEO to Executive Chairman.
|
| (2) |
Mr. Marron’s comparison data is impacted by his promotion to CEO during fiscal year 2017, and therefore, his 2017 compensation reflects eight months of his receiving compensation as CEO and four months of his compensation prior to his promotion.
|
|
Peer Group
|
|||
|
Ciber, Inc.
|
Black Box Corp.
|
CDW Corporation
|
|
|
PCM, Inc. (f/k/a PC Mall)
|
Datalink Corporation
|
ScanSource, Inc.
|
|
|
PC Connection Inc.
|
Insight Enterprises, Inc.
|
ManTech International Corp.
|
|
|
Presidio, Inc.
|
|||
|
Name and Principal Position
|
Year
|
Salary
($) |
Stock
Awards
($)(1) |
Non-Equity
Incentive Plan
Compensation
($)(2) |
All Other
Compensation
($)(3) |
Total
($) |
|||||||||||||||
|
Phillip G. Norton - Executive
|
2018
|
298,846
|
-
|
378,253
|
753,500
|
1,430,599
|
|||||||||||||||
|
Chairman of the Board
|
2017
|
465,000
|
778,558
|
428,088
|
262,220
|
1,933,866
|
|||||||||||||||
|
2016
|
766,989
|
900,900
|
806,475
|
8,184
|
2,482,548
|
||||||||||||||||
|
Mark P. Marron – President
|
2018
|
740,720
|
1,594,000
|
605,204
|
13,542
|
2,953,466
|
|||||||||||||||
|
and Chief Executive Officer
|
2017
|
641,666
|
1,615,558
|
261,609
|
11,765
|
2,530,598
|
|||||||||||||||
|
2016
|
515,341
|
4,013,100
|
492,846
|
9,598
|
5,030,885
|
||||||||||||||||
|
Elaine D. Marion – Chief
|
2018
|
443,504
|
956,400
|
313,950
|
14,211
|
1,728,065
|
|||||||||||||||
|
Finanical Officer
|
2017
|
415,000
|
778,558
|
190,261
|
11,211
|
1,395,030
|
|||||||||||||||
|
2016
|
412,012
|
2,457,000
|
358,433
|
11,797
|
3,239,242
|
||||||||||||||||
| (1) |
The values in this column represent the aggregate grant date fair values of restricted stock awards granted in the respective fiscal year, computed in accordance with
Codification Topic
Compensation
—Stock Compensation
. Assumptions used in calculating these values may be found in Note 11 of our financial statements in our 2018 Form 10-K. Each of these amounts reflect our expected aggregate accounting expense for these awards as of the grant date and do not necessarily correspond to the actual values that will be expensed by us or realized by the NEOs.
|
| (2) |
These amounts reflect cash payments made under our 2014 CIP during fiscal years 2018, 2017 and 2016, which reflect compensation earned during each prior respective fiscal year. A detailed description of the fiscal 2018 payments can be found in the CD&A.
|
| (3) |
Pursuant to his employment agreement, Mr. Norton received two retention payments during the year, one for $250,000 on July 31, 2017, and one for $500,000 on January 31, 2018. In accordance with the Company’s policy applicable to all eligible employees who decline health insurance, Ms. Marion receives a $100/month insurance waiver payment. Additionally, each of our executive officers received other compensation during fiscal years 2018, 2017 and 2016, in the form of an employer 401(k) match (which is available on the same terms to all employees), and Mr. Marron and Ms. Marion received travel, meals, and entertainment costs for their family to attend the Sales Meeting for our high-performers and executives. The amounts received by each named executive officer in fiscal year 2018 are enumerated below:
|
|
|
Other Compensation
|
|||||||||||||||||||
|
|
Employer
401K Match
|
Sales
Meeting (1) |
Retention
Payment
|
Medical
Insurance
Waiver
|
Total Other
|
|||||||||||||||
|
Phillip G. Norton
|
$
|
3,500
|
$
|
-
|
$
|
750,000
|
$
|
-
|
$
|
753,500
|
||||||||||
|
Mark P. Marron
|
$
|
3,500
|
$
|
10,042
|
$
|
-
|
$
|
-
|
$
|
13,542
|
||||||||||
|
Elaine D. Marion
|
$
|
3,500
|
$
|
9,511
|
$
|
-
|
$
|
1,200
|
$
|
14,211
|
||||||||||
| (1) |
The amounts shown reflect the costs incurred by the Company relating to the executives’ family’s attendance at the Sales Meeting, grossed up to cover the taxes incurred by the executive. This payment was received similarly by all attendees at the Sales Meeting.
|
|
|
|
Estimated
Possible Payouts Under Non-Equity Incentive Plan Awards(1) |
All Other
Stock
Awards:
Number of
Shares of
|
All Other
Option
Awards:
Number of
Securities
|
Exercise
or Base
Price of
|
Grant Date Fair
Value of Stock
|
|||||||||||||||||||||||
|
Name
|
Grant
Date
|
Threshold
($) |
Target
($) |
Maximum
($) |
Stock or
Units
(#)(2) |
Underlying
Options
(#) |
Option
Awards
($/Sh) |
and Option
Awards
($)(3) |
|||||||||||||||||||||
|
Phillip G. Norton
|
|
11,250
|
150,000
|
300,000
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Mark P. Marron
|
6/8/2017
|
20,000
|
-
|
-
|
1,594,000
|
||||||||||||||||||||||||
|
|
|
45,000
|
600,000(4
|
)
|
1,200,000
|
||||||||||||||||||||||||
|
Elaine D. Marion
|
6/8/2017
|
12,000
|
-
|
-
|
956,400
|
||||||||||||||||||||||||
|
|
|
18,750
|
250,000(5
|
)
|
500,000
|
||||||||||||||||||||||||
| (1) |
These amounts reflect award opportunities under the 2014 CIP and are described more fully in the CD&A under the heading “Components of Compensation and 2018 Compensation Determinations” and subheading “Cash Compensation.” Threshold amounts represent minimal level of achievement of the lowest weighted financial performance metric, and maximum amounts represent 200% of target values. Actual payments with respect to the awards for 2017 are disclosed in the Non-Equity Incentive Plan Compensation column of the 2018 Summary Compensation Table.
|
| (2) |
These amounts represent the number of shares of restricted stock granted to the NEOs under our 2012 Employee LTIP. Equity awards granted to the executive officers and reflected in the 2018 Grants of Plan-Based Awards Table vest equally over a three-year period, and may be accelerated in limited circumstances as set forth in the Employee LTIP, award agreements, and/or employment agreements.
|
| (3) |
These amounts reflect the grant date fair value of the restricted stock granted in fiscal year 2018. This represents the aggregate amount that we expected to expense for such grants in accordance with Codification Topic
Compensation
—Stock Compensation
over the grants’ respective service period. These amounts do not necessarily correspond to the actual values that will be expensed by us or realized by the NEOs. Assumptions used in calculating these values with respect to restricted stock awards may be found in Note 11 of our 2018 Annual Report.
|
| (4) |
On June 8, 2017, the Award was amended to increase the target bonus from $400,000 to $600,000.
|
| (5) |
On June 8, 2017, the Award was amended to increase the target bonus from $207,500 to $250,000.
|
|
Stock Awards
|
||||||||
|
Name
|
Number of Shares or
Units of Stock That
Have Not Vested (1)
|
Market Value of Shares or
Units of Stock That Have Not
Vested ($) (2)
|
||||||
|
Phillip G. Norton
|
16,343
|
1,269,851
|
||||||
|
Mark P. Marron
|
104,146
|
8,092,144
|
||||||
|
Elaine D. Marion
|
60,012
|
4,662,932
|
||||||
| (1) |
The following table shows the dates on which the outstanding stock awards as of March 31, 2018, will vest, subject to continued employment through the vest date, or acceleration in limited circumstances as set forth in the 2012 Employee LTIP, award agreements, and/or employment agreements.
|
|
Number of Shares
|
||||||||||||
|
Vest Date
|
Phillip G. Norton
|
Mark P. Marron
|
Elaine D. Marion
|
|||||||||
|
6/8/18
|
-
|
6,666
|
4,000
|
|||||||||
|
6/16/18
|
9,009
|
6,006
|
6,006
|
|||||||||
|
6/17/18
|
7,334
|
19,600
|
12,000
|
|||||||||
|
7/21/18
|
-
|
6,667
|
-
|
|||||||||
|
6/8/19
|
-
|
6,667
|
4,000
|
|||||||||
|
6/16/19
|
-
|
6,006
|
6,006
|
|||||||||
|
6/17/19
|
-
|
19,600
|
12,000
|
|||||||||
|
7/21/19
|
-
|
6,667
|
-
|
|||||||||
|
6/8/20
|
-
|
6,667
|
4,000
|
|||||||||
|
6/17/20
|
-
|
19,600
|
12,000
|
|||||||||
| (2) |
Because the markets were closed on the last business day of our fiscal year, which was March 30, 2018, the market value was computed by multiplying the closing price of our common stock ($77.70) on the last trading day of our fiscal year, March 29, 2018, by the number of shares in the first column.
|
|
Stock Awards
|
||||||||
|
Name
|
Number of Shares Acquired
on Vesting (#)
|
Value Realized on Vesting
($)(1)
|
||||||
|
Phillip G. Norton
|
16,343
|
1,223,860
|
||||||
|
Mark P. Marron
|
41,340
|
3,153,183
|
||||||
|
Elaine D. Marion
|
27,074
|
2,057,036
|
||||||
| (1) |
Market value was computed by multiplying the closing price of our common stock on the day of vesting by the number of shares acquired. Additionally, the restricted stock shares were net-share settled such that the Company withheld shares with value equivalent to the NEOs’ minimum statutory tax obligation for the applicable income and other employment taxes, and remitted cash to the appropriate taxing authorities. The amounts in the table represent the gross number of shares and value realized on vesting for each of the NEOs. The net number of shares acquired by Mr. Norton, Mr. Marron, and Ms. Marion was 9,756, 22,358, and 15,438, respectively.
|
| · |
Mr. Norton’s Amended & Restated Employment Agreement, which was entered into on December 12, 2017, terminates on July 31, 2018. On July 11, 2018, the Company announced that Mr. Norton will retire as an employee of ePlus effective July 31, 2018, however, he will continue to serve as Executive Chairman of our Board of Directors (a non-employee director position).
|
| · |
During the term of Mr. Norton’s employment agreement, a severance payment upon termination of employment by the Company “without cause,” or by Mr. Norton for “good reason,” as those terms are defined in the agreement, would have resulted in severance as set forth in a schedule attached to the agreement. As of March 31, 2018, the severance due would be $100,000. The severance amount is reduced to $0 in July 2018. Mr. Norton would also be entitled to, at the Company’s election, either the acceleration of unvested restricted stock, or cash in an amount equal to the value of the stock on the date of termination. During the fiscal year ended March 31, 2018, pursuant to the agreement, Mr. Norton would have been entitled to a pro-rated payment under our CIP, to the extent that Performance Goals are met, with the payment to be made at the time the payment would have been made had there been no termination of employment.
|
| · |
In the event of Mr. Norton’s death, or termination due to disability during the employment term, the employment agreement provided for a cash severance as set forth in a schedule attached to the agreement; a pro-rated payment under our Cash Incentive Plan, to the extent that Performance Goals were met, with the payment to be made at the time the payment would have been made had there been no termination of employment; and an acceleration of any unvested restricted stock, as set forth in the 2012 Employee LTIP and Mr. Norton’s award agreement.
|
| · |
In exchange for Mr. Norton’s ongoing assistance with, among other things, the leadership transition as Mr. Marron moved into the CEO role, Mr. Norton’s agreement provided for three retention payments on the following schedule: $250,000 on January 31, 2017, $250,000 on July 31, 2017, and $500,000 on January 31, 2018.
|
| · |
In the event Mr. Norton’s employment was terminated due to disability, by the Company without Good Cause or by Mr. Norton for Good Reason (all as defined in the agreement), the Company also would be responsible to pay Mr. Norton an amount in cash equal to the cost of premiums the Company paid prior to the date of termination for Mr. Norton and his spouse’s qualified coverage under the Company’s medical, prescription, dental, and other health benefits, through the earlier of 18 months after the termination date, July 31, 2018, or the date that he or his spouse become ineligible for COBRA.
|
| · |
Mr. Norton’s agreement also set his CIP target award for fiscal year 2018 at $150,000.
|
|
Triggering Event
|
Cash Severance
|
Target Cash
Incentive (1)
|
Equity-Based
Compensation
Awards(2)(3)
|
Benefits
|
Total
|
|||||||||||||||
|
Termination Without Cause, or for Good Reason, as defined in the agreement
|
$
|
104,218
|
$
|
150,000
|
$
|
1,269,851
|
$
|
-
|
$
|
1,524,069
|
||||||||||
|
Change in Control
|
$
|
-
|
$
|
1,269,851
|
$
|
-
|
$
|
1,269,851
|
||||||||||||
|
Death or Disability
|
$
|
104,218
|
$
|
150,000
|
$
|
1,269,851
|
$
|
-
|
$
|
1,524,069
|
||||||||||
| (1) |
In the event of death, disability, termination without cause, or termination for good reason, all as defined in the agreement, Mr. Norton would have been entitled to a pro-rated payment under our 2014 CIP, to the extent that the Performance Goals have been met, with the payment to be made after the end of the fiscal year at the time the payment would have been made had there been no termination. The above table assumes the target goal is reached but not exceeded.
|
| (2) |
The value of the equity-based compensation awards for all termination tables herein is as of March 30, 2018, the last business day of our fiscal year, however, since the markets were closed on that day, we used the closing price of our common stock ($77.70) on the last trading day of our fiscal year, March 29, 2018.
|
| (3) |
Pursuant to the 2012 Employee LTIP, and our standard award agreements, upon death or a change in control, as defined by the 2012 Employee LTIP, all unvested stock for all employees will vest.
|
| · |
Effective as of December 12, 2017.
|
| · |
Mr. Marron’s agreement has a termination date of January 31, 2018, however, the agreement contains automatic two-year successive renewal periods unless either party terminates the agreement 60 days prior to the end of the then-current term. As no notice of termination was provided, the expiration date of his agreement is now January 31, 2020.
|
| · |
In the event of disability, termination without cause, or termination for good reason (all as defined in the agreement), Mr. Marron is entitled to eighteen months of his base salary, in addition to a pro-rated payment under our CIP, to the extent that the Performance Goals have been met, with the payment to be made after the end of the fiscal year at the time the payment would have been made had there been no termination.
|
| · |
In the event of termination without cause, or by Mr. Marron for good reason, he is also entitled to, at the Company’s election, either the acceleration of unvested restricted stock, or cash in an amount equal to the value of the stock on the date of termination.
|
| · |
In the event of termination without cause by the Company or for good reason by Mr. Marron, the Company also would be responsible to pay Mr. Marron an amount in cash equal to the cost of premiums the Company paid prior to the date of termination for Mr. Marron and his dependents’ qualified coverage under the Company’s medical, prescription, dental, and other health benefits, for 18 months.
|
| · |
Mr. Marron’s employment agreement was amended on June 8, 2017, to increase his base salary to $750,000, and again on July 16, 2018, to increase his base salary to $800,000, effective April 1, 2018.
|
|
Triggering Event
|
Cash Severance
|
Target Cash
Incentive (2)
|
Equity-Based
Compensation
Awards(3)
|
Benefits
|
Total
|
|||||||||||||||
|
Termination Without Cause, or for Good Reason, as defined in the agreement
|
$
|
1,153,875
|
$
|
600,000
|
$
|
8,092,144
|
$
|
-
|
$
|
9,846,019
|
||||||||||
|
Change in Control
|
$
|
-
|
$
|
8,092,144
|
$
|
-
|
$
|
8,092,144
|
||||||||||||
|
Death or Disability (1)
|
$
|
1,153,875
|
$
|
600,000
|
$
|
8,092,144
|
$
|
-
|
$
|
9,846,019
|
||||||||||
| (1) |
The Cash Severance column assumes disability. No cash severance is due in the event of death.
|
| (2) |
In the event of disability, termination without cause or by Mr. Marron for good reason, all as defined in the agreement, Mr. Marron is entitled to a pro-rated amount of the payment under our CIP, to the extent that the Performance Goals have been met, with the payment to be made after the end of the fiscal year at the time the payment would have been made had there been no termination. The above table assumes the target goal is reached but not exceeded.
|
| (3) |
Pursuant to the 2012 Employee LTIP, and our standard award agreements, upon death or a change in control, as defined by the 2012 Employee LTIP, all unvested stock for all employees will vest. The value of the equity-based compensation awards for all termination tables herein is as of March 30, 2018, the last business day of our fiscal year, however, since the markets were closed on that day, we used the closing price of our common stock ($77.70) on the last trading day of our fiscal year, March 29, 2018.
|
| · |
Effective as of December 12, 2017.
|
| · |
Ms. Marion’s agreement has a termination date of July 31, 2018, however, the agreement contains automatic one-year successive renewal periods unless either party terminates the agreement 60 days prior to the end of the then-current term. As no notice of termination was provided, the expiration date of her agreement is now July 31, 2019.
|
| · |
In the event of disability, termination without cause, or termination for good reason (all as defined in the agreement), Ms. Marion is entitled to twelve months of her base salary, in addition to a pro-rated amount of the payment under our CIP.
|
| · |
In the event of termination without cause or by Ms. Marion for good reason, she is also entitled to, at the Company’s election, either the acceleration of unvested restricted stock, or cash in an amount equal to the value of the stock on the date of termination.
|
| · |
In the event of termination without cause by the Company or for good reason by Ms. Marion, an amount in cash equal to the cost of premiums the Company paid prior to the date of termination for Ms. Marion and her dependents’ qualified coverage under the Company’s medical, prescription, dental, and other health benefits, for 18 months.
|
| · |
Ms. Marion’s employment agreement was amended on June 8, 2017, to increase her base salary to $450,000.
|
|
Triggering Event
|
Cash Severance
|
Target Cash
Incentive (2)
|
Equity-Based
Compensation
Awards(3)
|
Benefits
|
Total
|
|||||||||||||||
|
Termination Without Cause, or for Good Reason, as defined in the agreement
|
$
|
450,000
|
$
|
250,000
|
$
|
4,662,932
|
$
|
-
|
$
|
5,362,932
|
||||||||||
|
Change in Control
|
$
|
-
|
$
|
-
|
$
|
4,662,932
|
$
|
-
|
$
|
4,662,932
|
||||||||||
|
Death or Disability (1)
|
$
|
450,000
|
$
|
250,000
|
$
|
4,662,932
|
$
|
-
|
$
|
5,362,932
|
||||||||||
| (1) |
The Cash Severance column assumes disability. No cash severance is due in the event of death.
|
| (2) |
In the event of disability, termination by the Company without cause, or by Ms. Marion for good reason, all as defined in the agreement, Ms. Marion is entitled to a pro-rated amount of the payment under our CIP. The above table assumes the target goal is reached but not exceeded.
|
| (3) |
The value of the equity-based compensation awards for all termination tables herein is as of March 30, 2018, the last business day of our fiscal year, however, since the markets were closed on that day, we used the closing price of our common stock ($77.70) on the last trading day of our fiscal year, March 29, 2018.
|
|
Plan Category
|
Number of securities
to be issued upon
exercise of
outstanding options,
warrants, and rights
|
Weighted
average
exercise price
of outstanding
options,
warrants, and
rights
|
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
first column)
|
|||||||||
|
Equity compensation plans approved by security holders
|
-
|
n/a
|
905,683(1
|
)
|
||||||||
|
Equity compensation plans not approved by security holders
|
-
|
n/a
|
-
|
|||||||||
|
Total
|
-
|
905,683
|
||||||||||
| (1) |
This number includes 144,442 shares reserved for issuance under the 2017 Non-Employee Director Long-Term Incentive Plan and available for future restricted stock awards, and 761,241 shares reserved for issuance under the 2012 Employee LTIP and available for future awards.
|
|
Submitted by the Audit Committee
|
|
|
Terrence O’Donnell, Chairman
|
|
|
John E. Callies
|
|
|
C. Thomas Faulders, III
|
|
|
Lawrence S. Herman
|
|
|
Fiscal 2018 ($)
|
Fiscal 2017 ($)
|
||||||
|
Audit Fees
|
$
|
1,755,448
|
$
|
1,654,062
|
||||
|
Audit Related Fees
|
-
|
-
|
||||||
|
Tax Related Fees
|
202,799
|
-
|
||||||
|
All Other Fees
|
1,895
|
1,895
|
||||||
|
TOTAL FEES
|
$
|
1,960,142
|
$
|
1,655,957
|
||||
| · |
By telephone
– You may use the toll-free telephone number shown on your Notice or proxy card;
|
| · |
Via the Internet
– You may visit the Internet website shown on your Notice or proxy card and follow the on-screen instructions;
|
| · |
By mail
– You may date, sign, and promptly return your proxy card by mail in a postage prepaid envelope; or
|
| · |
In person
– You may deliver a completed proxy card at the meeting or vote in person.
|
| · |
Non-Discretionary Items.
The election of directors (Proposal 1) and the advisory vote to approve Named Executive Officer compensation (Proposal 2) may not be voted on by your broker if it has not received voting instructions.
|
| · |
Discretionary Items.
The ratification of Deloitte as the Company’s independent registered public accounting firm (Proposal 3) is a discretionary item. Generally, brokers that do not receive voting instructions from beneficial owners may vote on this proposal in their discretion.
|
| · |
Mailing written notice of revocation or change to our Corporate Secretary at ePlus, 13595 Dulles Technology Drive, Herndon, Virginia, 20171;
|
| · |
Delivering a later-dated proxy (either in writing, by telephone, or via the Internet); or
|
| · |
Voting in person at the meeting.
|
|
July 27, 2018
|
By Order of the Board of Directors
|
|
Erica S. Stoecker
|
|
|
Corporate Secretary & General Counsel
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|